<?xml version="1.0" encoding="UTF-8"?>
<ref id="irv12697-bib-0096">
 <label>96</label>
 <mixed-citation publication-type="journal" id="irv12697-cit-0096">
  <string-name>
   <surname>Lövgren Bengtsson</surname>
   <given-names>K</given-names>
  </string-name>, 
  <string-name>
   <surname>Morein</surname>
   <given-names>B</given-names>
  </string-name>, 
  <string-name>
   <surname>Osterhaus</surname>
   <given-names>A</given-names>
  </string-name>. 
  <article-title>ISCOM technology‐based Matrix M
   <sup>TM</sup> adjuvant: success in future vaccines relies on formulation
  </article-title>. 
  <source xml:lang="en">Expert Rev Vaccines</source>. 
  <year>2011</year>;
  <volume>10</volume>(
  <issue>4</issue>):
  <fpage>401</fpage>‐
  <lpage>403</lpage>.
  <pub-id pub-id-type="pmid">21506635</pub-id>
 </mixed-citation>
</ref>
